{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T13:44:37Z","timestamp":1778507077206,"version":"3.51.4"},"reference-count":65,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T00:00:00Z","timestamp":1717459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Campus France","award":["143317Q"],"award-info":[{"award-number":["143317Q"]}]},{"name":"Government of Sudan","award":["143317Q"],"award-info":[{"award-number":["143317Q"]}]},{"name":"Rabelais Foundation, University of Tours","award":["143317Q"],"award-info":[{"award-number":["143317Q"]}]},{"name":"University of Tours","award":["143317Q"],"award-info":[{"award-number":["143317Q"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Toxoplasma gondii holds significant therapeutic potential; however, its nonspecific invasiveness results in off-target effects. The purpose of this study is to evaluate whether T. gondii specificity can be improved by surface display of scFv directed against dendritic cells\u2019 endocytic receptor, DEC205, and immune checkpoint PD-L1. Anti-DEC205 scFv was anchored to the T. gondii surface either directly via glycosylphosphatidylinositol (GPI) or by fusion with the SAG1 protein. Both constructs were successfully expressed, but the binding results suggested that the anti-DEC-SAG1 scFv had more reliable functionality towards recombinant DEC protein and DEC205-expressing MutuDC cells. Two anti-PD-L1 scFv constructs were developed that differed in the localization of the HA tag. Both constructs were adequately expressed, but the localization of the HA tag determined the functionality by binding to PD-L1 protein. Co-incubation of T. gondii displaying anti-PD-L1 scFv with tumor cells expressing\/displaying different levels of PD-L1 showed strong binding depending on the level of available biomarker. Neutralization assays confirmed that binding was due to the specific interaction between anti-PD-L1 scFv and its ligand. A mixed-cell assay showed that T. gondii expressing anti-PD-L1 scFv predominately targets the PD-L1-positive cells, with negligible off-target binding. The recombinant RH-PD-L1-C strain showed increased killing ability on PD-L1+ tumor cell lines compared to the parental strain. Moreover, a co-culture assay of target tumor cells and effector CD8+ T cells showed that our model could inhibit PD1\/PD-L1 interaction and potentiate T-cell immune response. These findings highlight surface display of antibody fragments as a promising strategy of targeting replicative T. gondii strains while minimizing nonspecific binding.<\/jats:p>","DOI":"10.3390\/cells13110975","type":"journal-article","created":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T05:17:30Z","timestamp":1717478250000},"page":"975","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Specific Cell Targeting by Toxoplasma gondii Displaying Functional Single-Chain Variable Fragment as a Novel Strategy; A Proof of Principle"],"prefix":"10.3390","volume":"13","author":[{"given":"Muna","family":"Aljieli","sequence":"first","affiliation":[{"name":"BioMAP, UMR ISP 1282 INRAE, Universit\u00e9 de Tours, 37200 Tours, France"},{"name":"Faculty of Pharmacy, University of Gezira, Wad Madani 21111, Sudan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cl\u00e9ment","family":"Rivi\u00e8re","sequence":"additional","affiliation":[{"name":"BioMAP, UMR ISP 1282 INRAE, Universit\u00e9 de Tours, 37200 Tours, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis","family":"Lantier","sequence":"additional","affiliation":[{"name":"BioMAP, UMR ISP 1282 INRAE, Universit\u00e9 de Tours, 37200 Tours, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9171-5711","authenticated-orcid":false,"given":"Nathalie","family":"Moir\u00e9","sequence":"additional","affiliation":[{"name":"BioMAP, UMR ISP 1282 INRAE, Universit\u00e9 de Tours, 37200 Tours, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zineb","family":"Lakhrif","sequence":"additional","affiliation":[{"name":"BioMAP, UMR ISP 1282 INRAE, Universit\u00e9 de Tours, 37200 Tours, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-France","family":"Boussemart","sequence":"additional","affiliation":[{"name":"BioMAP, UMR ISP 1282 INRAE, Universit\u00e9 de Tours, 37200 Tours, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Cnudde","sequence":"additional","affiliation":[{"name":"BioMAP, UMR ISP 1282 INRAE, Universit\u00e9 de Tours, 37200 Tours, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7299-6407","authenticated-orcid":false,"given":"Laurie","family":"Lajoie","sequence":"additional","affiliation":[{"name":"BioMAP, UMR ISP 1282 INRAE, Universit\u00e9 de Tours, 37200 Tours, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3211-0186","authenticated-orcid":false,"given":"Nicolas","family":"Aubrey","sequence":"additional","affiliation":[{"name":"BioMAP, UMR ISP 1282 INRAE, Universit\u00e9 de Tours, 37200 Tours, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elhadi M.","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, University of Gezira, Wad Madani 21111, Sudan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Dimier-Poisson","sequence":"additional","affiliation":[{"name":"BioMAP, UMR ISP 1282 INRAE, Universit\u00e9 de Tours, 37200 Tours, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4826-0333","authenticated-orcid":false,"given":"Anne","family":"Di-Tommaso","sequence":"additional","affiliation":[{"name":"BioMAP, UMR ISP 1282 INRAE, Universit\u00e9 de Tours, 37200 Tours, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-No\u00eblle","family":"M\u00e9v\u00e9lec","sequence":"additional","affiliation":[{"name":"BioMAP, UMR ISP 1282 INRAE, Universit\u00e9 de Tours, 37200 Tours, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,6,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.mib.2006.06.017","article-title":"Pulling together: An integrated model of Toxoplasma cell invasion","volume":"10","author":"Carruthers","year":"2007","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Daher, D., Shaghlil, A., Sobh, E., Hamie, M., Hassan, M.E., Moumneh, M.B., Itani, S., El Hajj, R., Tawk, L., and El Sabban, M. (2021). Comprehensive overview of toxoplasma gondii-induced and associated diseases. Pathogens, 10.","DOI":"10.3390\/pathogens10111351"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00281-012-0339-3","article-title":"Immune response and immunopathology during toxoplasmosis","volume":"34","author":"Dupont","year":"2012","journal-title":"Semin. Immunopathol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.3181\/00379727-131-34066","article-title":"Resistance to Virus Challenge in Mice Infected with Protozoa or Bacteria","volume":"131","author":"Remington","year":"1969","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1126\/science.160.3823.72","article-title":"Immunity and Intracellular Infection: Resistance to Bacteria in Mice Infected with a Protozoan","volume":"160","author":"Ruskin","year":"1968","journal-title":"Science"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/263056a0","article-title":"Acquired resistance to infection with Schistosoma mansoni induced by Toxoplasma gondii","volume":"263","author":"Mahmoud","year":"1976","journal-title":"Nature"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/infdis\/123.1.22","article-title":"Resistance against Cryptococcus Conferred by Intracellular Bacteria and Protozoa","volume":"123","author":"Gentry","year":"1971","journal-title":"J. Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/infdis\/124.6.587","article-title":"Resistance to murine tumors conferred by chronic infection with intracellular protozoa, Toxoplasma gondii and Besnoitia jellisoni","volume":"124","author":"Hibbs","year":"1971","journal-title":"J. Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1093\/jnci\/59.3.963","article-title":"Nonspecific inhibition of tumor growth in the central nervous system: Observations of intracerebral ependymoblastoma in mice with chronic Toxoplasma infection","volume":"59","author":"Conley","year":"1977","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2350778","DOI":"10.1002\/eji.202350778","article-title":"Current advances in bacteria-based cancer immunotherapy","volume":"54","author":"Guo","year":"2024","journal-title":"Eur. J. Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13045-020-00922-1","article-title":"Oncolytic viruses for cancer immunotherapy","volume":"13","author":"Hemminki","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/cr.2009.126","article-title":"VEGI-armed oncolytic adenovirus inhibits tumor neovascularization and directly induces mitochondria-mediated cancer cell apoptosis","volume":"20","author":"Xiao","year":"2010","journal-title":"Cell Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1038\/s41467-023-39224-8","article-title":"Bioengineering of bacteria for cancer immunotherapy","volume":"14","author":"Nguyen","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"410819","DOI":"10.3389\/fimmu.2018.02052","article-title":"The journey of in vivo virus engineered dendritic cells from bench to bedside: A Bumpy Road","volume":"9","author":"Goyvaerts","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_15","unstructured":"Kumar, S. (2019). Pharmaceuticals from Microbes: The Bioengineering Perspective, Springer."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e1115641","DOI":"10.1080\/2162402X.2015.1115641","article-title":"First oncolytic virus approved for melanoma immunotherapy","volume":"5","author":"Pol","year":"2016","journal-title":"Oncoimmunology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.pt.2016.04.013","article-title":"The Past, Present, and Future of Genetic Manipulation in Toxoplasma gondii","volume":"32","author":"Wang","year":"2016","journal-title":"Trends Parasitol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/415926a","article-title":"De novo pyrimidine biosynthesis is required for virulence of Toxoplasma gondii","volume":"415","author":"Fox","year":"2002","journal-title":"Nature"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"469","DOI":"10.4049\/jimmunol.1201209","article-title":"Immune-Mediated Regression of Established B16F10 Melanoma by Intratumoral Injection of Attenuated Toxoplasma gondii Protects against Rechallenge","volume":"190","author":"Baird","year":"2013","journal-title":"J. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e26296","DOI":"10.4161\/onci.26296","article-title":"Non-replicating Toxoplasma gondii reverses tumor-associated immunosuppression","volume":"2","author":"Fox","year":"2013","journal-title":"Oncoimmunology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1158\/2326-6066.CIR-14-0235","article-title":"Attenuated Toxoplasma gondii stimulates immunity to pancreatic cancer by manipulation of myeloid cell populations","volume":"3","author":"Sanders","year":"2015","journal-title":"Cancer Immunol. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1007\/s00436-021-07283-9","article-title":"Antitumor effects of a Toxoplasma mutant lacking lactate dehydrogenases","volume":"120","author":"Li","year":"2021","journal-title":"Parasitol. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e002970","DOI":"10.1136\/jitc-2021-002970","article-title":"Synergy between Toxoplasma gondii type I \u0394GRA17 immunotherapy and PD-L1 checkpoint inhibition triggers the regression of targeted and distal tumors","volume":"9","author":"Zhu","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1173379","DOI":"10.3389\/fimmu.2023.1173379","article-title":"Toxoplasma gondii gra5 deletion mutant protects hosts against Toxoplasma gondii infection and breast tumors","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Fox, B.A., Sanders, K.L., Rommereim, L.M., Guevara, R.B., and Bzik, D.J. (2016). Secretion of Rhoptry and Dense Granule Effector Proteins by Nonreplicating Toxoplasma gondii Uracil Auxotrophs Controls the Development of Antitumor Immunity. PLoS Genet., 12.","DOI":"10.1371\/journal.pgen.1006189"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41392-023-01407-6","article-title":"Oncolytic virotherapy: Basic principles, recent advances and future directions","volume":"8","author":"Lin","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"911783","DOI":"10.3389\/fimmu.2022.911783","article-title":"Current Status and Future Directions of Bacteria-Based Immunotherapy","volume":"13","author":"Tang","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Bourque, J., and Hawiger, D. (2022). Applications of Antibody-Based Antigen Delivery Targeted to Dendritic Cells In Vivo. Antibodies, 11.","DOI":"10.3390\/antib11010008"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3389\/fimmu.2018.00317","article-title":"Targeted Delivery of Toxoplasma gondii Antigens to Dendritic Cells Promote Immunogenicity and Protective Efficiency against Toxoplasmosis","volume":"9","author":"Lakhrif","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12934-015-0290-9","article-title":"Surface display of an anti-DEC-205 single chain Fv fragment in Lactobacillus plantarum increases internalization and plasmid transfer to dendritic cells in vitro and in vivo","volume":"14","author":"Christophe","year":"2015","journal-title":"Microb. Cell Fact."},{"key":"ref_31","first-page":"4576","article-title":"Evidence for glycosyl-phosphatidylinositol anchoring of Toxoplasma gondii major surface antigens","volume":"9","author":"Tomavo","year":"1989","journal-title":"Mol. Cell Biol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Theisen, T.C., and Boothroyd, J.C. (2022). Transcriptional signatures of clonally derived Toxoplasma tachyzoites reveal novel insights into the expression of a family of surface proteins. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0262374"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1634\/theoncologist.2017-0087","article-title":"FDA Approval Summary: Atezolizumab for the Treatment of Patients with Progressive Advanced Urothelial Carcinoma after Platinum-Containing Chemotherapy","volume":"22","author":"Ning","year":"2017","journal-title":"Oncologist"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"4534","DOI":"10.1158\/1078-0432.CCR-17-0540","article-title":"U.S. Food and Drug Administration approval summary: Atezolizumab for metastatic non\u2013small cell lung cancer","volume":"23","author":"Weinstock","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"90215","DOI":"10.18632\/oncotarget.21652","article-title":"Structural basis of the therapeutic anti-PD-L1 antibody atezolizumab","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"5532","DOI":"10.1038\/s41598-017-06002-8","article-title":"Molecular mechanism of PD-1\/PD-L1 blockade via anti-PD-L1 antibodies atezolizumab and durvalumab","volume":"7","author":"Lee","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0166-6851(98)00011-5","article-title":"Expression, selection, and organellar targeting of the green fluorescent protein in Toxoplasma gondii","volume":"92","author":"Striepen","year":"1998","journal-title":"Mol. Biochem. Parasitol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1126\/science.8235614","article-title":"Gene Replacement in Toxoplasma gondii with Chloramphenicol Acetyltransferase as Selectable Marker","volume":"262","author":"Kim","year":"1993","journal-title":"Science"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1128\/MCB.15.1.87","article-title":"A selector of transcription initiation in the protozoan parasite Toxoplasma gondii","volume":"15","author":"Soldati","year":"1995","journal-title":"Mol. Cell Biol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.4049\/jimmunol.141.10.3584","article-title":"Molecular analysis of the gene encoding the major surface antigen of Toxoplasma gondii","volume":"141","author":"Burg","year":"1988","journal-title":"J. Immunol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/1756-3305-7-180","article-title":"Research progress on surface antigen 1 (SAG1) of Toxoplasma gondii","volume":"7","author":"Wang","year":"2014","journal-title":"Parasit. Vectors"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1084\/jem.163.4.981","article-title":"Langerhans\u2019 cells, veiled cells, and interdigitating cells in the mouse recognized by a monoclonal antibody","volume":"163","author":"Kraal","year":"1986","journal-title":"J. Exp. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"6222","DOI":"10.1128\/IAI.71.11.6222-6228.2003","article-title":"The MIC3 Gene of Toxoplasma gondii Is a Novel Potent Vaccine Candidate against Toxoplasmosis","volume":"71","author":"Sekkai","year":"2003","journal-title":"Infect. Immun."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0031182000066695","article-title":"Surface antigens of Toxoplasma gondii","volume":"97","author":"Couvreur","year":"1988","journal-title":"Parasitology"},{"key":"ref_45","first-page":"331","article-title":"Novel murine dendritic cell lines: A powerful auxiliary tool for dendritic cell research","volume":"3","author":"Grosjean","year":"2012","journal-title":"Front. Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.molimm.2008.11.016","article-title":"CD205 (DEC-205): A recognition receptor for apoptotic and necrotic self","volume":"46","author":"Shrimpton","year":"2009","journal-title":"Mol. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1536012117718459","article-title":"Noninvasive Imaging of Immune Checkpoint Ligand PD-L1 in Tumors and Metastases for Guiding Immunotherapy","volume":"16","author":"Chatterjee","year":"2017","journal-title":"Mol. Imaging"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"101960","DOI":"10.1016\/j.isci.2020.101960","article-title":"Human and mouse PD-L1: Similar molecular structure, but different druggability profiles","volume":"24","author":"Kocik","year":"2021","journal-title":"iScience"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e1963","DOI":"10.1002\/cnr2.1963","article-title":"A potential cure for tumor-associated immunosuppression by Toxoplasma gondii","volume":"7","author":"Lotfalizadeh","year":"2024","journal-title":"Cancer Rep."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1172\/JCI34224","article-title":"The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells","volume":"118","author":"Nchinda","year":"2008","journal-title":"J. Clin. Investig."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1006\/meth.1997.0503","article-title":"Targeting the secretory pathway of Toxoplasma gondii","volume":"13","author":"Karsten","year":"1997","journal-title":"Methods"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"6027","DOI":"10.1128\/IAI.71.10.6027-6034.2003","article-title":"Expression of Cpgp40\/15 in Toxoplasma gondii: A surrogate system for the study of cryptosporidium glycoprotein antigens","volume":"71","author":"Kim","year":"2003","journal-title":"Infect. Immun."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.4049\/jimmunol.165.4.2084","article-title":"Recombinant attenuated Toxoplasma gondii expressing the Plasmodium yoelii circumsporozoite protein provides highly effective priming for CD8+ T cell-dependent protective immunity against malaria","volume":"165","author":"Charest","year":"2000","journal-title":"J. Immunol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1021\/cb500462t","article-title":"One-step enzymatic modification of the cell surface redirects cellular cytotoxicity and parasite tropism","volume":"10","author":"Swee","year":"2015","journal-title":"ACS Chem. Biol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1089\/hum.2011.016","article-title":"A transductionally retargeted adenoviral vector for virotherapy of her2\/neu-expressing prostate cancer","volume":"23","author":"Magnusson","year":"2012","journal-title":"Hum. Gene Ther."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Nanni, P., Gatta, V., Menotti, L., De Giovanni, C., Ianzano, M., Palladini, A., Grosso, V., Dall\u2019Ora, M., Croci, S., and Nicoletti, G. (2013). Preclinical Therapy of Disseminated HER-2+ Ovarian and Breast Carcinomas with a HER-2-Retargeted Oncolytic Herpesvirus. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003155"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/gt.2010.150","article-title":"CD20-targeted measles virus shows high oncolytic specificity in clinical samples from lymphoma patients independent of prior rituximab therapy","volume":"18","author":"Yaiw","year":"2011","journal-title":"Gene Ther."},{"key":"ref_58","first-page":"705","article-title":"Salmonella engineered to express CD20-targeting antibodies and a drug-converting enzyme can eradicate human lymphomas","volume":"122","author":"Massa","year":"2013","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.2147\/OTT.S105862","article-title":"PD-L1 expression in human cancers and its association with clinical outcomes","volume":"9","author":"Wang","year":"2016","journal-title":"Onco Targets Ther."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.molmed.2014.10.009","article-title":"Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway","volume":"21","author":"Ohaegbulam","year":"2015","journal-title":"Trends Mol. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/jcp.27172","article-title":"PD-1\/PD-L1 immune checkpoint: Potential target for cancer therapy","volume":"234","author":"Dermani","year":"2019","journal-title":"J. Cell Physiol."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Kuklik, J., Michelfelder, S., Schiele, F., Kreuz, S., Lamla, T., M\u00fcller, P., and Park, J.E. (2021). Development of a Bispecific Antibody-Based Platform for Retargeting of Capsid Modified AAV Vectors. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22158355"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"7392","DOI":"10.1039\/D1BM00928A","article-title":"Surface engineering of oncolytic adenovirus for a combination of immune checkpoint blockade and virotherapy","volume":"9","author":"Lv","year":"2021","journal-title":"Biomater. Sci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13568-023-01509-y","article-title":"Development of fluorescence-labeled antibody for immune checkpoint inhibitor using engineered probiotics","volume":"13","author":"Namai","year":"2023","journal-title":"AMB Express"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ni.2035","article-title":"T cell exhaustion","volume":"12","author":"Wherry","year":"2011","journal-title":"Nat. Immunol."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/13\/11\/975\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:53:26Z","timestamp":1760108006000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/13\/11\/975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,4]]},"references-count":65,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["cells13110975"],"URL":"https:\/\/doi.org\/10.3390\/cells13110975","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,4]]}}}